Statins, bone metabolism and treatment of bone catabolic diseases

Pharmacological Research

Volumn 88, Issue , 2014, Pages 53-61

  Zhang, Yijia ^a   Bradley, Aaron D ^b   Wang, Dong ^a   Reinhardt, Richard A ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bone fracture; Bone metabolism; Osteoporosis; Periodontitis; Statins

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE ISOENZYME; ATORVASTATIN; BETA CYCLODEXTRIN; BONE MORPHOGENETIC PROTEIN 2; CARBOXY TERMINAL TELOPEPTIDE; CERIVASTATIN; COMPACTIN; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; FARNESYL DIPHOSPHATE; FLUINDOSTATIN; GERANYLGERANYL PYROPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PITAVASTATIN; SIMVASTATIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VITAMIN D;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTHRITIS; BONE DEFECT; BONE DENSITY; BONE DEVELOPMENT; BONE IMPLANT; BONE MASS; BONE METABOLISM; BONE REGENERATION; BONE STRENGTH; BONE TURNOVER; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENTIATION; FRACTURE; FRACTURE HEALING; HUMAN; HUMAN CELL; INCIDENCE; LONG BONE; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PERIODONTITIS; PLEIOTROPY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PRENYLATION; RAT; REVIEW; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; ANIMAL; BONE; BONE DISEASES; DRUG EFFECTS; METABOLISM;

ANIMALS; BONE AND BONES; BONE DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 84906791607     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.12.009     Document Type: Review

References (120)

1. G. Mundy, R. Garrett, S. Harris, J. Chan, D. Chen, and G. Rossini et al. Stimulation of bone formation in vitro and in rodents by statins Science 286 1999 1946 1949 (Pubitemid 129515901)
2. G.R. Mundy Statins and their potential for osteoporosis Bone 29 2001 495 497 (Pubitemid 33124289)
3. S.B. Jadhavand, and G.K. Jain Statins and osteoporosis: new role for old drugs J Pharm Pharmacol 58 2006 3 18 (Pubitemid 43041991)
4. M.M. Weivodaand, and R.J. Hohl Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation Endocrinology 152 2011 3113 3122
5. M.M. Weivodaand, and R.J. Hohl The effects of direct inhibition of geranylgeranyl pyrophosphate synthase on osteoblast differentiation J Cell Biochem 112 2011 1506 1513
6. T. Yoshida, M. Asanuma, L. Grossmann, M. Fuse, T. Shibata, and T. Yonekawa et al. Geranylgeranyl-pyrophosphate (GGPP) synthase is down-regulated during differentiation of osteoblastic cell line MC3T3-E1 FEBS Lett 580 2006 5203 5207 (Pubitemid 44415791)
7. F. Ruan, Q. Zheng, and J. Wang Mechanisms of bone anabolism regulated by statins Biosci Rep 32 2012 511 519
8. K. Ohnaka, S. Shimoda, H. Nawata, H. Shimokawa, K. Kaibuchi, and Y. Iwamoto et al. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts Biochem Biophys Res Commun 287 2001 337 342 (Pubitemid 32917601)
9. G. Luisetto, and V. Camozzi Statins, fracture risk, and bone remodeling J Endocrinol Invest 32 2009 32 37
10. C.H. Heldin, K. Miyazono, and P. ten Dijke TGF-beta signaling from cell membrane to nucleus through SMAD proteins Nature 390 1997 465 471 (Pubitemid 28013118)
11. A.J. Borton, J.P. Frederick, M.B. Datto, X.F. Wang, and R.S. Weinstein The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis J Bone Miner Res 16 2001 1754 1764 (Pubitemid 32911480)
12. H. Kaji, J. Naito, Y. Inoue, H. Sowa, T. Sugimoto, and K. Chihara Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta Smad3 pathway Horm Metab Res 40 2008 746 751
13. S. Khosla Minireview: the OPG/RANKL/RANK system Endocrinology 142 2001 5050 5055 (Pubitemid 33131929)
14. H. Kaji, M. Kanatani, T. Sugimoto, and K. Chihara Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures Horm Metab Res 37 2005 589 592 (Pubitemid 41597568)
15. F. Syedand, and S. Khosla Mechanisms of sex steroid effects on bone Biochem Biophys Res Commun 328 2005 688 696 (Pubitemid 40214350)
16. C. Song, J. Wang, Q. Song, X. Li, Z. Chen, and Q. Ma et al. Simvastatin induces estrogen receptor-alpha (ER-alpha) in murine bone marrow stromal cells J Bone Miner Metab 26 2008 213 217 (Pubitemid 351677840)
17. X. Li, Q.S. Song, J.Y. Wang, H.J. Leng, Z.Q. Chen, and Z.J. Liu et al. Simvastatin induces estrogen receptor-alpha expression in bone, restores bone loss, and decreases ER alpha expression and uterine wet weight in ovariectomized rats J Bone Miner Metab 29 2011 396 403
18. J.T. Woo, S. Kasai, P.H. Stern, and K. Nagai Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts J Bone Miner Res 15 2000 650 662 (Pubitemid 30174019)
19. B. Yavuz, D.T. Ertugrul, H. Cil, N. Ata, K.O. Akin, and A.A. Yalcin et al. Increased levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins Cardiovasc Drugs Ther 23 2009 295 299
20. D.T. Ertugrul, B. Yavuz, H. Cil, N. Ata, K.O. Akin, and M. Kucukazman et al. STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25-hydroxyvitamin D Cardiovasc Ther 29 2011 146 152
21. L. Rejnmark, P. Vestergaard, L. Heickendorff, and L. Mosekilde Simvastatin does not affect vitamin D status, but low vitamin D levels are associated with dyslipidemia: results from a randomised, controlled trial Int J Endocrinol 2010 10.1155/2010/957174
22. K.E. Thummel, C. Brimer, K. Yasuda, J. Thottassery, T. Senn, and Y. Lin et al. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxyvitamin D3 Mol Pharmacol 60 2001 1399 1406 (Pubitemid 33144911)
23. L. Drocourt, J.C. Ourlin, J.M. Pascussi, P. Maurel, and M.J. Vilarem Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes J Biol Chem 277 2002 25125 25132 (Pubitemid 34951818)
24. S. Bhattacharyya, K. Bhattacharyya, and A. Maitra Possible mechanisms of interaction between statins and vitamin D QJM 105 2013 487 491
25. J.B. Schwartz Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence Clin Pharmacol Ther 85 2009 198 203
26. B. Skoglund, C. Forslund, and P. Aspenberg Simvastatin improves fracture healing in mice J Bone Miner Res 17 2002 2004 2008 (Pubitemid 35239202)
27. M.-L. Ho, Y.-H. Chen, H.-J. Liao, C.H. Chen, S.-H. Hung, and M.-J. Lec et al. Simvastatin increases osteoblasts and osteogenic proteins in ovariectomized rats Eur J Clin Invest 39 2009 296 303
28. Y. Uyar, Y. Baytur, U. Inceboz, B.C. Demir, G. Gumuser, and K. Ozbilgin Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats Maturitas 63 2009 261 267
29. P. Goes, A.P.S. Lima, I.M. Melo, R.O.C.C. Rego, and V. Lima Effect of atorvastatin in radiographic density on alveolar bone loss in Wistar rats Braz Dent J 21 2010 193 198
30. R. Hanayama, H. Shimizu, H. Nakagami, M.K. Osako, H. Makino, and Y. Kunugiza et al. Fluvastatin improves osteoporosis in fructose-fed insulin resistant model rats through blockade of the classical mevalonate pathway and antioxidant action Int J Mol Med 23 2009 581 588
31. H. Yin, Z.G. Shi, Y.S. Yu, J. Hu, R. Wang, and Z.P. Luan et al. Protection against osteoporosis by statins is linked to a reduction of oxidative stress and restoration of nitric oxide formation in aged and ovariectomized rats Eur J Pharmacol 674 2012 200 206
32. N. Seferos, A. Pantopoulou, A. Kotsiou, G. Rallis, and C. Tesseromatis The influence of simvastatin in rats mandible and femur bone mass under Freund's adjuvant arthritis Stomatologija 14 2012 46 52
33. R. Dalcico, A.M. de Menezes, B. Deocleciano, R.B. Oriá, M.L. Vale, and R.A. Ribeiro et al. Protective mechanisms of simvastatin in experimental periodontal disease J Periodontol 84 2013 1145 1157
34. J. Banu, and D.N. Kalu Site-specific effects of cerivastatin on bone in male Sprague-Dawley rats Bone 34 2004 432 442 (Pubitemid 38314908)
35. A.L. Anbinder, A. Prado Fde, A. Prado Mde, I. Balducci, and R.F. Rocha The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats Braz Oral Res 21 2007 247 252
36. A.J. Yee, H.W. Bae, D. Friess, S.M. Roth, C. Whyne, and M. Robbin et al. The use of simvastatin in rabbit posterolateral lumbar intertransverse process spine fusion Spine J 6 2006 391 396 (Pubitemid 43977196)
37. J.L. Funk, J. Chen, K.J. Downey, and R.A. Clark Bone protective effect of simvastatin in experimental arthritis J Rheumatol 35 2008 1083 1091 (Pubitemid 351813156)
38. I. Gradosova, H. Zivna, V. Palicka, S. Hubena, K. Svejkovska, and P. Zivny Protective effect of atorvastatin on bone tissue in orchidectomised male albino Wistar rats Eur J Pharmacol 15 2012 144 150
39. S. Abdul-Majeed, N. Mohamed, and I.N. Soelaiman Effects of tocotrienol and lovastatin combination on osteoblast and osteoclast activity in estrogen-deficient osteoporosis Evid Based Complement Alternat Med 2012 10.1155/2012/960742
40. J.A. Handal, T.K. John, D.T. Goldstein, J.S. Khurana, M. Saing, and L.E. Braitman et al. Effects of atorvastatin on the cortical bones of corticosteroid treated rabbits J Orthop Res 30 2012 872 876
41. J.W. Starnes, D.B. Neidre, J.S. Nyman, A. Roy, M.J. Nelson, and G. Gutierrez et al. Synergistic effect of exercise and statins on femoral strength in rats Exp Gerontol 48 2013 751 755
42. K.A. Chan, S.E. Andrade, M. Boles, D.S. Buist, G.A. Chase, and J.G. Donahue et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women Lancet 355 2000 2185 2188 (Pubitemid 30394324)
43. J.A. Pasco, M.A. Kotowicz, M.J. Henry, K.M. Sanders, G.C. Nicholson Geelong Osteoporosis Study Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study Arch Intern Med 162 2002 537 540 (Pubitemid 34193540)
44. T.P. van Staa, S. Wegman, F. de Vries, B. Leufkens, and C. Cooper Use of statins and risk of fractures JAMA 285 2001 1850 1855 (Pubitemid 32289152)
45. L. Rejnmark, N.H. Buus, P. Vestergaard, F. Andreasen, M.L. Larsen, and L. Mosekilde Statins decrease bone turnover in postmenopausal women: a cross-sectional study Eur J Clin Invest 32 2002 581 589 (Pubitemid 36223410)
46. A.Z. LaCroix, J.A. Cauley, M. Pettinger, J. Hsia, D.C. Bauer, and J. McGowan et al. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study Ann Intern Med 139 2003 97 104
47. D.H. Solomon, J.S. Finkelstein, P.S. Wang, and J. Avorn Statin lipid-lowering drugs and bone mineral density Pharmacoepidemiol Drug Saf 14 2005 219 226 (Pubitemid 40528851)
48. L.N. Bakhireva, M.R. Shainline, S. Carter, S. Robinson, S.J. Beaton, and J.J. Nawarskas et al. Synergistic effect of statins and postmenopausal hormone therapy in the prevention of skeletal fractures in elderly women Pharmacotherapy 30 2010 879 887
49. Y.S. Chung, M.D. Lee, S.K. Lee, H.M. Kim, and L.A. Fitzpatrick HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients J Clin Endocrinol Metab 85 2000 1137 1142 (Pubitemid 32269362)
50. A. Nakashima, R. Nakashima, T. Ito, T. Masaki, and N. Yorioka HMG-CoA reductase inhibitors prevent bone loss in patients with type 2 diabetes mellitus Diabet Med 21 2004 1020 1024 (Pubitemid 39215323)
51. J. Cunha-Cruz, B. Saver, G. Maupome, and P.P. Hujoel Statin use and tooth loss in chronic periodontitis patients J Periodontol 77 2006 1061 1066 (Pubitemid 44740623)
52. T. Saxlin, L. Suominen-Taipale, M. Knuuttila, P. Alha, and P. Ylöstalo Dual effect of statin medication on periodontium J Clin Periodontol 36 2009 997 1003
53. J. Sirola, J. Sirola, R. Honkanen, H. Kröger, J.S. Jurvelin, and P. Mäenpää et al. Relation of statin use and bone loss: a prospective population-based cohort study in early postmenopausal women Osteoporos Int 13 2002 537 541 (Pubitemid 34790625)
54. A. Montagnani, S. Gonnelli, C. Cepollaro, S. Pacini, M.S. Campagna, and M.B. Franci et al. Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study Bone 32 2003 427 433 (Pubitemid 36410317)
55. T.R. Pedersen, J. Kjekshus, K. Berg, T. Haghfelt, O. Faergeman, G. Faergeman Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).1994 Atheroscler Suppl 5 2004 81 87
56. M. Gotoh, K. Mizuno, Y. Ono, and M. Takahashi Fluvastatin increases bone mineral density in postmenopausal women Fukushima J Med Sci 57 2011 19 27
57. J.L. Hernández, J.M. Olmos, G. Romaña, J. Martinez, J. Castillo, and I. Yezerska et al. Bone mineral density in statin users: a population-based analysis from a Spanish cohort J Bone Miner Metab 2013 [Epub ahead of print]
58. I.R. Reid, W. Hague, J. Emberson, J. Baker, A. Tonkin, and D. Hunt et al. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised control trial. Long-term intervention with pravastatin in ischaemic disease Lancet 357 2001 509 512 (Pubitemid 32173587)
59. J.R. Downs, M. Clearfield, H.A. Tyroler, E.J. Whitney, W. Kruyer, and A. Langendorfer et al. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional prospectives on tolerability of long-term treatment with lovastatin Am J Cardiol 87 2001 1074 1079 (Pubitemid 32710322)
60. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo-controlled trial Lancet 360 2002 7 22
61. L. Rejnmark, N.H. Buus, P. Vestergaard, L. Heickendorff, F. Andreasen, and M.L. Larsen et al. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women J Bone Miner Res 19 2004 737 744 (Pubitemid 41094384)
62. G. Lupattelli, A.M. Scarponi, G. Vaudo, D. Siepi, A.R. Roscini, and F. Gemelli et al. Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women Metabolism 53 2004 744 748 (Pubitemid 38880905)
63. H.G. Bone, D.P. Kiel, R.S. Lindsay, E.M. Lewiecki, M.A. Bolognese, and E.T. Leary et al. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial J Clin Endocrinol Metab 92 2007 4671 4677 (Pubitemid 350223443)
64. M.E. Fajardo, M.L. Rocha, F.J. Sánchez-Marin, and E.J. Espinosa-Chávez Effect of atorvastatin on chronic periodontitis: a randomized pilot study J Clin Periodontol 37 2010 1016 1022
65. E.A. Stein, M. Farnier, J. Waldstreicher, M. Mercuri Simvastatin/ Atorvastatin Study Group Effects of statins on biomarkers of bone metabolism: a randomised trial Nutr Metab Cardiovasc Dis 11 2001 84 87 (Pubitemid 33687811)
66. R.S. Rosenson, C.C. Tangney, C.B. Langman, T.S. Parker, D.M. Levine, and B.R. Gordon Short-term reduction in bone markers with high-dose simvastatin Osteoporos Int 16 2005 1272 1276 (Pubitemid 41396956)
67. T. Majima, A. Shimatsu, Y. Komatsu, N. Satoh, A. Fukao, and K. Ninomiya et al. Short-term effects of pitavastatin on biochemical markers of bone turnover in patients with hypercholesterolemia Intern Med 46 2007 1967 1973
68. S. Chuengsmarn, S. Rattanamongkoulgul, S. Suwanwalaikorn, S. Wattanasirichaigoon, and L. Kaufman Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia Bone 46 2010 1011 1015
69. N.H. Bjarnason, B.J. Riis, and C. Christiansen The effect of fluvastatin on parameters of bone remodeling Osteoporosis Int 12 2001 380 384 (Pubitemid 32606462)
70. Y. Sertbas, U. Ersoy, M. Ayter, F. Gultekin Tirtil, and B. Kucukkaya Ezetimibe effect on bone mineral density and marker of bone formation and resorption J Investig Med 58 2010 295 297
71. D.C. Bauer, G.R. Mundy, S.A. Jamal, D.M. Black, J.A. Cauley, and K.E. Ensrud et al. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials Arch Intern Med 164 2004 146 152 (Pubitemid 38140400)
72. C. Hatzigeorgiou, and J.L. Jackson Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis Osteoporos Int 16 2005 990 998 (Pubitemid 41127110)
73. I.D. Nguyen, C.Y. Wang, J.A. Eisman, and T.V. Nguyen On the association between statin and fracture: a Bayesian consideration Bone 40 2007 813 820 (Pubitemid 46386539)
74. B. Uzzan, R. Cohen, P. Nicolas, M. Cucherat, and G.Y. Perret Effects of statins on bone mineral density: a meta-analysis of clinical studies Bone 40 2007 1581 1587 (Pubitemid 46779004)
75. S. Toh, and S. Hernández-Diaz Statins and fracture risk: a systematic review Pharmacoepidemiol Drug Saf 16 2007 627 640 (Pubitemid 47039529)
76. A. Beri, N. Sural, and S.B. Mahajan Non-atheroprotective effects of statins: a systematic review Am J Cardiovasc Drugs 9 2009 361 370
77. J. Yue, X. Zhang, B. Dong, and M. Yang Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials Menopause 17 2010 1071 1079
78. B. Skoglund, and P. Aspenberg Locally applied simvastatin improves fracture healing in mice BMC Musculoskelet Disord 8 2007 98
79. J.W. Wang, S.W. Xu, D.S. Yang, and R.K. Lv Locally applied simvastatin promotes fracture healing in ovariectomized rat Osteoporos Int 18 2007 1641 1650 (Pubitemid 47620312)
80. S. Pauly, F. Luttosch, M. Morawski, N.P. Haas, G. Schmidmaier, and B. Wildermann Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application Bone 45 2009 505 511
81. W. Wang, J.S. Nyman, H.E. Moss, G. Gutierrez, G.R. Mundy, and X. Yang et al. Local low-dose lovastatin delivery improves the healing defect caused by Nf1 loss of function in osteoblasts J Bone Miner Res 25 2010 1658 1667
82. T. Fukui, M. Ii, T. Shoji, T. Matsumoto, Y. Mifune, and Y. Kawakami et al. Therapeutic effect of local administration of low-dose simvastatin- conjugated gelatin hydrogel for fracture healing J Bone Miner Res 27 2012 1118 1131
83. Y. Moriyama, Y. Ayukawa, Y. Ogino, I. Atsuta, and K. Koyano Topical application of statin affects bone healing around implants Clin Oral Implants Res 19 2008 600 605
84. Y. Moriyama, Y. Ayukawa, Y. Ogino, I. Atsuta, M. Todo, and Y. Takao et al. Local application of fluvastatin improves peri-implant bone quantity and mechanical properties: a rodent study Acta Biomater 6 2010 1610 1618
85. B. Ma, S.A. Clarke, R.A. Brooks, and N. Rushton The effect of simvastatin on bone formation and ceramic resorption in a peri-implant defect model Acta Biomater 4 2008 149 155 (Pubitemid 350131550)
86. S. Pauly, D.A. Back, K. Kaeppler, N.P. Haas, G. Schmidmaier, and B. Wildermann Influence of statins locally applied from orthopedic implants on osseous integration BMC Musculoskelet Disord 13 2012 208
87. Y. Ayukawa, E. Yasukawa, Y. Moriyama, Y. Ogino, H. Wada, and I. Atsuta et al. Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats Oral Med Oral Pathol Oral Radiol Endod 107 2009 336 342
88. M. Monjo, M. Rubert, J.C. Wohfahrt, H.J. Rønold, J.E. Ellingsen, and S.P. Lyngstadaas In vivo performance of absorbable collagen sponges with rosuvastatin in critical-size cortical bone defects Acta Biomater 6 2010 1405 1412
89. T. Yoshii, A.E. Hafeman, J.M. Esparza, A. Okawa, G. Gutierrez, and S.A. Guelcher Local injection of lovastatin in biodegradable polyurethane scaffolds enhances bone regeneration in critical-sized segmental defect in rat femora J Tissue Eng Regen Med 2012 [Epub ahead of print]
90. J.A. Cottrell, F.M. Vales, D. Schachter, S. Wadsworth, R. Gundlapalli, and R. Kapadia et al. Osteogenic activity of locally applied small molecule drugs in a rat femur defect model J Biomed Biotechnol 2010 10.1155/2010/597641
91. F. von Knoch, C. Wedemeyer, A. Heckelei, G. Saxler, G. Hilken, and J. Brankamp et al. Promotion of bone formation by simvastatin in polyethylene particle-induced osteolysis Biomaterials 26 2005 5783 5789 (Pubitemid 40798269)
92. J.H. Jeon, W.T. Piepgrass, Y.L. Lin, M.V. Thomas, and D.A. Puleo Localized intermittent delivery of simvastatin hydroxyacid stimulates bone formation in rats J Periodontol 79 2008 1457 1464
93. M. Nyan, D. Sato, H. Kihara, T. Machida, K. Ohya, and S. Kasugai Effects of the combination with alpha-tricalcium phosphate and simvastatin on bone regeneration Clin Oral Implants Res 20 2009 280 287
94. S. Alam, K. Ueki, K. Nakagawa, K. Marukawa, Y. Hashiba, and E. Yamamoto et al. Statin-induced bone morphogenetic protein 2 (BMP2) expression during bone regeneration: an immunohistochemical study Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 2009 22 29
95. M. Nyan, T. Miyahara, K. Noritake, J. Hao, R. Rodriguez, and S. Kuroda et al. Molecular and tissue responses in the healing of rat calvarial defects after local application of simvastatin combined with alpha tricalcium phosphate J Biomed Mater Res B Appl Biomater 93 2010 65 73
96. K. Tanabe, H. Nomoto, N. Okumori, T. Miura, and M. Yoshinari Osteogenic effect of fluvastatin combined with biodegradable gelatin-hydrogel Dent Mater J 31 2012 489 493
97. C.E. Lima, J.C. Calixto, and A.L. Anbinder Influence of the association between simvastatin and demineralized bovine bone matrix on bone repair in rats Braz Oral Res 25 2011 42 48
98. J.C. Calixto, C.E. Lima, L. Frederico, R.P. Lima, and A.L. Anbinder The influence of local administration of simvastatin in calvarial bone healing in rats J Craniomaxillofac Surg 39 2011 215 220
99. D. Stein, Y. Lee, M.J. Schmid, B. Killpack, M.A. Genrich, and N. Narayana et al. Local simvastatin effects on mandibular bone growth and inflammation J Periodontol 76 2005 1861 1870 (Pubitemid 41748975)
100. I. Ozec, E. Kilic, C. Gumus, and F. Goze Effect of local simvastatin application on mandibular defects J Craniofac Surg 18 2007 546 550 (Pubitemid 46849954)
101. J.D. Bradley, D.G. Cleverly, A.M. Burns, N.B. Helm, M.J. Schmid, and D.B. Marx et al. Cyclooxygenase-2 inhibitor reduces simvastatin-induced bone morphogenetic protein-2 and bone formation in vivo J Periodontal Res 42 2007 267 273
102. Y. Lee, M.J. Schmid, D.B. Marx, M.W. Beatty, D.M. Cullen, and M.E. Collins et al. The effect of local simvastatin delivery strategies on mandibular bone formation in vivo Biomaterials 29 2008 1940 1949
103. Z. Wu, C. Liu, and G. Zang The effect of simvastatin on remodeling of the alveolar bone following tooth extraction Int J Oral Maxillofac Surg 37 2008 170 176 (Pubitemid 351220967)
104. N. Marciel-Oliveira, V. Bradaschia-Correa, and V.E. Arana-Chavez Early alveolar bone regeneration in rats after topical administration of simvastatin Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 2011 170 179
105. J. Rutledge, M.D. Schieber, J.M. Chamberlain, M. Byarlay, A.C. Killeen, and P.J. Giannini et al. Simvastatin application to augment facial jaw bone in a dog model: pilot study J Periodontol 82 2011 597 605
106. S. Chen, J.Y. Yang, S.Y. Zhang, L. Feng, and J. Ren Effects of simvastatin gel on bone regeneration in alveolar defects in miniature pigs Chin Med J 124 2011 3953 3958
107. M. Morris, Y. Lee, M.T. Lavin, P.J. Giannini, M.J. Schmid, and D.B. Marx et al. Injectable simvastatin in periodontal defects and alveolar ridges: pilot studies J Periodontol 79 2008 1465 1473
108. E. Kilic, I. Ozec, H. Yeler, A. Korkmaz, B. Ayas, and C. Gumus Effects of simvastatin on mandibular distraction osteogenesis J Oral Maxillofac Surg 66 2008 2233 2238
109. H. Vaziri, R. Naserhojjati-Roodsari, N. Tahsili-Fahadan, A. Khojasteh, F. Mashhadi-Abbas, and B. Eslami et al. Effect of simvastatin administration on periodontitis-associated bone loss in ovariectomized rats J Periodontol 78 2007 1561 1567
110. H. Seto, H. Ohba, K. Tokunaga, H. Hama, M. Horibe, and T. Nagata Topical administration of simvastatin recovers alveolar bone loss in rats J Periodont Res 43 2008 261 267
111. U. Price, H. Le, S.E. Powell, M.J. Schmid, D.B. Marx, and Y. Zhang et al. Effects of local simvastatin-alendronate conjugate in preventing periodontitis bone loss J Periodontal Res 48 2013 541 548
112. A.R. Pradeep, and M.S. Thorat Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial J Periodontol 81 2010 214 222
113. A.R. Pradeep, N. Priyanka, N. Kalra, S.B. Naik, S.P. Singh, and S. Martande Clinical efficacy of subgingivally delivered 1.2-mg simvastatin in the treatment of individuals with class II furcation defects: a randomized controlled clinical trial J Periodontol 83 2012 1472 1479
114. A.R. Pradeep, N.S. Rao, P. Bajaj, and M. Kumari Efficacy of subingivally delivered simvastatin in the treatment of patients with type 2 diabetes and chronic periodontitis: a randomized double-masked controlled clinical trial J Periodontol 84 2013 24 31
115. A.R. Pradeep, M. Kumari, N.S. Rao, S.S. Martande, and S.B. Naik Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial J Periodontol 84 2013 871 879
116. Y. Zhang, Z. Jia, A. Dusad, A. Daluiski, E.V. Fehringer, and S.R. Goldring et al. A novel macromolecular prodrug of simvastatin promotes bone fracture repair in mice J Bone Miner Res 27 Suppl. 1 2012 S332
117. D. Wang, and S.R. Goldring The bone, the joints and the balm of Gilead Mol Pharm 8 2011 991 993
118. K. Ren, P.E. Purdue, L. Burton, L.D. Quan, E.V. Fehringer, and G.M. Thiele et al. Early detection and treatment of wear particle-induced inflammation and bone loss in a mouse calvarial osteolysis model using HPMA copolymer conjugates Mol Pharm 8 2011 1043 1051
119. F. Yuan, R.K. Nelson, D.E. Tabor, Y. Zhang, M.P. Akhter, and K.A. Gould et al. Dexamethasone prodrug treatment prevents ephritis in lupus-prone (NZB × NZW) F1 mice without causing systemic side effects Arthritis Rheum 64 2012 4029 4039
120. F. Yuan, L.D. Quan, L. Cui, S.R. Goldring, and D. Wang Development of macromolecular prodrug for rheumatoid arthritis Adv Drug Deliv Rev 64 2012 1205 1219